Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Clearing Lung" refers to the biological process of mucociliary clearance (MCC), a primary innate defense mechanism of the respiratory system. It is not a single molecular target or receptor but a physiological function involving the coordinated action of ciliary beating and the production and transport of airway surface liquid (ASL) and mucus [1, 15]. In therapeutic contexts, particularly within biotechnology and traditional medicine, "clearing the lung" involves the removal of mucus, cellular debris, and pathogens to restore respiratory function [2, 6, 12]. Key molecular drivers of this process include the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and the Epithelial Sodium Channel (ENaC), which regulate ion and water balance in the airways to maintain optimal mucus hydration [1, 12]. Additionally, in laboratory settings, the term can refer to tissue clearing (e.g., CLARITY), a technique used to make lung tissue transparent for high-resolution 3D imaging in research [4, 11]. Failure of lung clearance is a hallmark of diseases such as cystic fibrosis, primary ciliary dyskinesia, and chronic obstructive pulmonary disease (COPD) [1, 19].
Enhancement of chloride secretion via CFTR, inhibition of sodium absorption via ENaC, or enzymatic degradation of extracellular DNA and mucins to reduce mucus viscosity and facilitate airway transport [1, 10, 21].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lung mucociliary clearance (MCC).